Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report

Author(s):  Jones Nat, Carvalho Maria, Branvold-Herr Andrea

Issue:  May/Jun 2017 - Volume 21, Number 3
View All Articles in Issue

Abstract:  Skin conditions such as psoriasis and eczema negatively impact the patient’s quality of life; the primary goal of topical treatments is to minimize the disease-specific symptoms. This case report discusses the management of two refractory psoriasis skin lesions in an adult male using a topical compounded formula. The psoriasis symptoms were assessed quantitatively using two validated research instruments, the Psoriasis Symptom Inventory, and an adapted Numeric Rating Scale. A qualitative assessment was also performed by evaluating the digital photographs taken by the patient during the course of treatment. The compounded formula containing zinc pyrithione, clobetasol propionate, and cyanocobalamin in the Professional Compounding Centers of America’s proprietary base PCCA XemaTop, applied topically for three weeks, significantly reduced the patient’s self-reported psoriasis symptoms and improved his overall condition by 81.2%. This successful case report is important evidence for healthcare professionals when considering new, innovative topical compounded formulas for managing skin conditions such as psoriasis and eczema.

Related Keywords: Nat Jones, RPh, FIACP, Maria Carvalho, PharmD, MRPharmS, PhD, Andrea Branvold-Herr, MS, RPh, inflammatory skin disorders, psoriasis, eczema, autoimmune disease, dermatitis, dry skin, boswellic acid, avenanthramides, phosphatidylglycerol, ceramide, lamellar bilayers, case report, topical preparation, zinc pyrithione, topical corticosteroid, clobetasol proprionate micronized, cyanocobalamin, formulation, nitric oxide blocker, inflammation, anti-inflammatory agent, cytostatic agent, antimicrobial agent, patient self assessment, Psoriasis Symptom Inventory, numeric rating scale, patient-reported outcome


Printer-Friendly Version

Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Jones Nat, Carvalho Maria, Branvold-Herr Andrea May/Jun 2017 205-211 Buy
Basics of Compounding for Dry-Skin Conditions Allen Loyd V Jr Nov/Dec 2003 460-463 View Sample
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Williams LaVonn A, Fokken Dawn Sep/Oct 2009 386-389 Buy
Compounding for Skin Care: An Interview with John Hollis, RPh Vail Jane Mar/Apr 2002 85-86 Buy
The Treatment of Canine Atopic Disease Davidson Gigi S May/Jun 2002 210-215 Buy
Novel Approaches to Topical Psoriasis Therapy Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin Sep/Oct 2015 357-365 Buy
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S Jul/Aug 2020 337-345 Buy
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Zur Eyal Sep/Oct 2012 386-393 Buy
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Heustess Allie, Asbill Scott, Eagerton David, Arnold John Nov/Dec 2014 512-515 Buy
Pitch Ointment: Applications in Scar and Wound Management Kloesel Lawson, Carvalho Maria, Banov Fabiana May/Jun 2018 182-188 Buy